BIOSCRIPT MIDCO 2 LIMITED - Profile & Financials

Accounts Submitted 27 Jun 2025

Confirmation Statement Submitted 6 Feb 2025

Net assets £8.07M £900.00K 2024 year on year

Total assets £0.00 £95.47M 2024 year on year

Total Liabilities £48.06M £40.23M 2024 year on year

Charges 1

1 outstanding

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Credit Report

Discover BIOSCRIPT MIDCO 2 LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

N/A

Decreased by £44.15M (-100%)

Net Assets

£8.07M

Increased by £900.00k (+13%)

Total Liabilities

£48.06M

Decreased by £40.23M (-46%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Decreased by 92 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

4 Allotments 120,095,621 Shares £4.02m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
26 Apr 2024	ORDINARY	90,000,000	£900k	£0.01
29 Sept 2022	ORDINARY	29,999,420	£300k	£0.01
30 Jul 2021	ORDINARY	1	£23k	£23k
2 Mar 2021	ORDINARY	96,200	£2.80m	£29.114

Officers

2 active 4 resigned

Show resigned officers

						Status
Gabrielle Alison Silver	Director	British	England	52	2 May 2023	Active
James Maxwell	Director	British	United Kingdom	41	15 Feb 2024	Active

Shareholders

Shareholders (1)


Bioscript Midco 1 Limited	100.0%	522,342,829	Ordinary	6 Feb 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Bioscript Midco 1 Limited

Unknown

Active

Notified 19 Feb 2021

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

BIOSCRIPT MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOSCRIPT HOLDINGS LIMITED united kingdom significant influence or control

SOVEREIGN CAPITAL PARTNERS LLP united kingdom

BB SHELF 4 LLP united kingdom voting rights 75 to 100 percent limited liability partnership

BIOSCRIPT MIDCO 2 LIMITED Current Company

BIOSCRIPT LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

1 outstanding

Documents

Company Filings

Date	Category	Description	Document
27 Jun 2025	Accounts	Annual accounts made up to 2024-09-30	View(20 pages)
7 Feb 2025	Officers	Change to director Mr James Maxwell on 2025-02-06	View(2 pages)
6 Feb 2025	Confirmation Statement	Confirmation statement made on 2025-01-23 with updates	View(5 pages)
1 Oct 2024	Officers	Change to director Dr Gabrielle Alison Silver on 2024-09-24	View(2 pages)
1 Oct 2024	Persons With Significant Control	Change to Bioscript Midco 1 Limited as a person with significant control on 2024-09-24	View(2 pages)